- Home
- BRTX vs AEI Comparison
BRTX vs AEI Comparison
Compare BRTX & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- AEI
- Stock Information
- Founded
- BRTX 1997
- AEI 2014
- Country
- BRTX United States
- AEI United States
- Employees
- BRTX N/A
- AEI N/A
- Industry
- BRTX Managed Health Care
- AEI Building operators
- Sector
- BRTX Health Care
- AEI Real Estate
- Exchange
- BRTX Nasdaq
- AEI Nasdaq
- Market Cap
- BRTX 12.5M
- AEI 13.6M
- IPO Year
- BRTX N/A
- AEI N/A
- Fundamental
- Price
- BRTX $1.43
- AEI $3.18
- Analyst Decision
- BRTX
- AEI
- Analyst Count
- BRTX 0
- AEI 0
- Target Price
- BRTX N/A
- AEI N/A
- AVG Volume (30 Days)
- BRTX 102.2K
- AEI 1.5M
- Earning Date
- BRTX 11-11-2025
- AEI 11-13-2025
- Dividend Yield
- BRTX N/A
- AEI N/A
- EPS Growth
- BRTX N/A
- AEI N/A
- EPS
- BRTX N/A
- AEI N/A
- Revenue
- BRTX $605,200.00
- AEI $16,069,911.00
- Revenue This Year
- BRTX $232.67
- AEI N/A
- Revenue Next Year
- BRTX $52.92
- AEI N/A
- P/E Ratio
- BRTX N/A
- AEI N/A
- Revenue Growth
- BRTX 247.62
- AEI 74.28
- 52 Week Low
- BRTX $1.21
- AEI $0.70
- 52 Week High
- BRTX $2.55
- AEI $4.55
- Technical
- Relative Strength Index (RSI)
- BRTX 37.54
- AEI 59.29
- Support Level
- BRTX $1.56
- AEI $2.21
- Resistance Level
- BRTX $1.63
- AEI $4.55
- Average True Range (ATR)
- BRTX 0.10
- AEI 0.65
- MACD
- BRTX -0.02
- AEI 0.18
- Stochastic Oscillator
- BRTX 0.00
- AEI 57.19
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.